B-Cell Depletion by Anti-CD20 (Rituximab) in Renal Allograft Recipients Who Develop De Novo Anti-HLA Alloantibodies will Result in Inhibition of Alloantibody Production and Attenuation of Chronic Humoral Rejection (CTOT-02/CCTPT-02)

Grant

Awarded By

Total Award Amount

  • 260250.00

    • Direct Costs

  • 191897.00

    • Sponsor Award Id

    • Contributor

  • Vineeta Kumar   Principal Investigator